About APTABRIDGE THERAPEUTICS, INC.
Aptabridge Therapeutics is developing a next-generation drug design platform using DNA nanoparticles for immunotherapy, aiming to create safer, more cost-effective, and scalable treatments for complex diseases.
Development of highly stable multi-specific molecules targeting multiple disease pathwaysUse of DNA nanoparticles instead of antibodies for immunotherapyModular design strategy for mixing and matching binding modulesAI-augmented system for patient-specific therapeutic molecule synthesis in the clinicCombination of biologics and small molecule advantages
Is this your company?
Claim APTABRIDGE THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim APTABRIDGE THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.